Growth Metrics

Incyte (INCY) FCF Margin Growth (5y) (2015 - 2026)

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Quantum Biopharma 1,216,509.61 Bn 1,216,509.61 Bn -
2 Alterity Therapeutics 764,224.41 Bn 764,224.38 Bn -
3 Legend Biotech 2,716.00 Bn 2,715.71 Bn 242.10 Mn
4 Nanobiotix 2,248.83 Bn 2,248.77 Bn -
5 Akari Therapeutics 1,951.18 Bn 1,951.17 Bn -
6 Vertex Pharmaceuticals 113.69 Bn 106.44 Bn 2.59 Bn
7 Evaxion A 64.16 Bn 64.14 Bn -
8 Regeneron Pharmaceuticals 63.94 Bn 55.18 Bn 3.31 Bn
9 Alnylam Pharmaceuticals 40.13 Bn 37.12 Bn 959.66 Mn
10 Incyte 19.28 Bn 15.27 Bn 1.17 Bn

Historic Data

Download Data 🔒
DateValue
Mar 31, 2026 -235.00
Dec 31, 2025 2,009.00
Sep 30, 2025 1,128.00
Jun 30, 2025 -3,910.00
Mar 31, 2025 15,209.00
Dec 31, 2024 349.00
Sep 30, 2024 -2,499.00
Jun 30, 2024 -7,512.00
Mar 31, 2024 -280.00
Dec 31, 2023 -1,216.00
Sep 30, 2023 -2,059.00
Jun 30, 2023 2,720.00
Mar 31, 2023 -1,669.00
Dec 31, 2022 7,900.00
Sep 30, 2022 803.00
Jun 30, 2022 -875.00
Mar 31, 2022 7,794.00
Dec 31, 2021 -47.00
Sep 30, 2021 -3,791.00
Jun 30, 2021 3,756.00
Mar 31, 2021 -434.00
Dec 31, 2020 -1,473.00
Sep 30, 2020 3,267.00
Jun 30, 2020 3,584.00
Mar 31, 2020 -12,201.00
Dec 31, 2019 -628.00
Sep 30, 2019 4,585.00
Jun 30, 2019 4,329.00
Mar 31, 2019 6,586.00
Dec 31, 2018 5,313.00
Sep 30, 2018 5,373.00
Jun 30, 2018 -326.00
Mar 31, 2018 -3,139.00
Dec 31, 2017 -2,252.00
Sep 30, 2017 7,013.00
Jun 30, 2017 1,752.00
Mar 31, 2017 10,107.00
Dec 31, 2016 16,881.00
Sep 30, 2016 35,230.00
Jun 30, 2016 16,298.00
Mar 31, 2016 17,495.00
Dec 31, 2015 -167.00
Sep 30, 2015 17,473.00
Jun 30, 2015 1,362.00
Mar 31, 2015 -59,811.00